Possible scenario
Evidence Remains Mixed
25% Chance
Mexico continues to challenge the FDA's interpretation of traceback evidence, and the investigation does not produce a clean farm-level confirmation. The most likely consequence is a contested public record, not an immediate reversal of recalls already completed.
Portfolio impact
S&P 500-0.0%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.